v3.26.1
Stock-Based Compensation (Tables)
 6 Months Ended
Jun. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Option Activity
The following table summarizes the activities for all stock options under the Company’s stock-based compensation plans for the six months ended June 30, 2026:
Number of Options OutstandingWeighted-Average Exercise PriceWeighted-Average Remaining Contractual TermAggregate Intrinsic Value(1)
Outstanding as of December 31, 2025(2)7,958 $13.08 3.20 years$— 
Granted— $— 
Exercised(10)$2.68 
Forfeited or expired(3)(88)$18.02 
Outstanding as of June 30, 2026(2)7,860 $13.04 2.71 years$— 
Exercisable as of June 30, 2026(4)7,860 $13.04 2.71 years$— 
Vested and expected to vest as of June 30, 2026(5)7,842 $13.05 2.70 years$— 
(1)The intrinsic value is the amount by which the current market value of the underlying stock exceeds the exercise price of the stock awards.
(2)Includes 3,521 and 3,530 performance condition stock options as of June 30, 2026 and December 31, 2025, respectively.
(3)Includes 9 performance condition stock options.
(4)Includes 3,521 performance condition stock options.
(5)Includes 3,521 performance condition stock options.
Schedule of Restricted Stock Unit Activity
The following table summarizes the activities for all RSUs under the Company’s stock-based compensation plans for the six months ended June 30, 2026:
Number of SharesWeighted-Average Grant Date Fair Value Per Share
Outstanding as of December 31, 2025(1)2,316 $3.69 
Granted(2)1,318 $3.34 
Vested(616)$3.91 
Forfeited(3)(238)$3.34 
Outstanding as of June 30, 2026(1)2,780 $3.50 
(1)Includes 742 and 323 performance condition RSUs as of June 30, 2026 and December 31, 2025, respectively.
(2)Includes 580 performance condition RSUs.
(3)Includes 161 performance condition RSUs.
Schedule of Stock-Based Compensation Expense
The following table provides information about stock-based compensation expense by award type:
Three Months EndedSix Months Ended
June 30,
2026		June 30,
2025		June 30,
2026		June 30,
2025
Stock options$243 $255 $243 $— 
Restricted stock units813 1,061 1,602 2,087 
Employee stock purchase plan427 394 829 777 
Total stock-based compensation expense$1,483 $1,710 $2,674 $3,453 
The following table provides information about stock-based compensation expense by financial statement line item:
Three Months EndedSix Months Ended
June 30,
2026		June 30,
2025		June 30,
2026		June 30,
2025
Cost of revenue (exclusive of depreciation and amortization)$— $— $— $— 
Sales and marketing205 254 422 518 
Research and development261 276 516 594 
General and administrative1,017 1,180 1,736 2,341 
Total stock-based compensation expense$1,483 $1,710 $2,674 $3,453